Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

NCT00081536 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Aroplatin (Liposomal NDDP) in combination with capecitabine

Sponsor

Aronex Pharmaceuticals